Company
Headquarters: Tosu, Japan
Employees: 2,770
CEO: Mr. Hirotaka Nakatomi
¥278.30 Billion
JPY as of July 1, 2024
US$1.72 Billion
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals in Japan. The company provides analgesic / anti-inflammatory patches; athlete's foot / ringworm remedy products; allergy-only rhinitis drugs; eye drops; high cholesterol improving drugs; acne remedies; cooling sheets; and supporters for knee, waist, elbow, calf and ankle. It also provides cooling sprays; bactericidal antibacterial spray and deodorant spray; ship fixing sheet; adhesive plasters for magnetic products; skin care products; sweat sheet; massage roller gel and oil spray; thermal equipment, and dietary supplements. The company offers its products under the Salon pass, Salonship, Air Salon Pass, Fatus, Butena Rock, Allegra, Direct pasting, Choleston, Life Cera, Deco Deco Cool, Children Robin Eye Plus. Eye cool, MSM, and other brand names. It sells its products in North America, Central and South America, Asia, Oceania, the Middle East, Africa, and Europe. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Hisamitsu Pharmaceutical Co., Inc. has the following listings and related stock indices.
Stock: JPX: 4530 wb_incandescent
Stock: FSX: HPX wb_incandescent